greeksoup/ stock research

Elevance Health (ELV) FY2025 results: revenue $199.1 billion, up 12.5% on the year

Elevance Health, Inc. (ELV) reported revenue of $199.1 billion for fiscal 2025, the year ended 31 December 2025, up 12.5% on the year before. Net income was $5.7 billion, down 5.3%, and diluted earnings per share $25.21. The figures are the company's own, from the 10-K it filed with the SEC on 6 February 2026.

Revenue
$199.1 billion
+12.5% on the year
FY2018FY2025
Operating margin
3.6%
4.4% a year earlier
FY2018FY2025
Net income
$5.7 billion
-5.3% on the year
FY2018FY2025
Diluted EPS
$25.21
-1.8% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

What management said about the year

Guidance figures: 22 new.

  • Revenue rose 10 percent in quarter: Operating revenue was $49.3 billion in the fourth quarter, up 10 percent, driven by higher premium yields, acquisitions and Medicare Advantage growth, partly offset by Medicaid attrition.
  • Quarterly and annual EPS figures reported: Fourth quarter diluted EPS was $2.47 against $1.81, and adjusted diluted EPS was $3.33 against $3.23. Full year diluted EPS was $25.21 and adjusted diluted EPS $30.29, against $33.04.
  • Health Benefits swung to adjusted loss: Health Benefits reported an adjusted operating loss of $0.2 billion in the fourth quarter and an adjusted operating gain of $4.2 billion for the year. Both periods were affected mainly by higher medical cost trend.
  • Medical membership down 1 percent: Medical membership was about 45.2 million at December 31, 2025, down 0.5 million, driven by Medicaid attrition. Medicare Advantage membership rose 7.9 percent to 2.23 million.
  • Cost trend in ACA and Part D: The fourth quarter benefit expense ratio of 93.5 percent rose 110 basis points, reflecting higher medical cost trend in ACA health plans and Medicare Part D seasonality from Inflation Reduction Act changes.
Read the Q4 FY2025 earnings call summary

From this 10-K

Elevance Health sells health cover and health services. It served approximately 45.2 million medical members through its affiliated health plans at the end of 2025, and describes itself as one of the largest health insurers in the United States by medical membership. Its position rests on something structural: it is an independent licensee of the Blue Cross and Blue Shield Association, which gives it the Blue brands in a defined list of states.

Elevance Health, Inc., the 10-K for 2025

Elevance Health sells health cover and health services. It served approximately 45.2 million medical members through its affiliated health plans at the end of 2025, and describes itself as one of the largest health insurers in the United States by medical membership. Its position rests on something structural: it is an independent licensee of the Blue Cross and Blue Shield Association, which gives it the Blue brands in a defined list of states.

Where it holds the Blue licence

It is the Blue Cross licensee for California, and the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri excluding 30 counties around Kansas City, Nevada, New Hampshire, New York in the New York City metropolitan area and upstate, Ohio, Virginia excluding the Northern Virginia suburbs of Washington D.C., and Wisconsin. In most of those areas it trades as Anthem Blue Cross, or Anthem Blue Cross and Blue Shield. It also works through arrangements with other Blue licensees and other partners, and serves members in many states under the Wellpoint, Carelon, MMM and Simply Healthcare names.

The two ways it gets paid

This is the distinction that matters in health insurance, and the filing draws it plainly. In the risk-based business, Elevance takes the premium and carries the cost of the care: it offers network-based managed care plans in the Individual, Employer Group, Medicaid and Medicare markets.

In the fee-based business it does not carry that risk. It sells managed care services to customers who fund their own claims, covering claims processing, stop loss insurance, access to its care provider network, medical management, care management, wellness programmes, actuarial services and other administration.

Revenue therefore comes from three places: risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through the Carelon businesses.

The other things it sells

Specialty services are sold both to members of its own health plans and to health plans it does not own: pharmacy services, stop loss insurance, dental, vision and supplemental health benefits, and integrated health services. Separately, the Federal Health Products & Services business serves the federal government and administers the Federal Employee Program.

How the company describes itself

Elevance states that it is focused on enhancing well-being and advancing health outcomes by delivering integrated whole health solutions across the care journey, supporting consumers with medical, pharmacy and behavioural health services. It says it advances that mission by working with care providers and community organisations.

From Elevance Health's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 6 February 2026: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue199,125177,011171,340+12.5%
Cost of revenue21,17819,75017,293+7.2%
Gross profit177,947157,261154,047+13.2%
Gross margin89.4%88.8%89.9%
Selling, general and administrative20,98420,02520,087+4.8%
Operating income7,1997,8628,499-8.4%
Operating margin3.6%4.4%5.0%
Interest expense1,4021,1851,030+18.3%
Pre-tax income6,7107,9047,715-15.1%
Income tax1,0491,9331,724-45.7%
Effective tax rate15.6%24.5%22.3%
Net income5,6625,9805,987-5.3%
Net margin2.8%3.4%3.5%
Diluted EPS$25.21$25.68$25.22-1.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow4,2905,8088,061-26.1%
Capital expenditure1,1161,2561,296-11.1%
Free cash flow3,1744,5526,765-30.3%
Free cash flow margin1.6%2.6%3.9%
Cash from investing-1,344-5,167-5,572
Cash from financing-1,7381,193-3,349
Depreciation and amortisation1,5461,3931,745+11.0%
Share-based compensation276191289+44.5%
Buybacks2,6052,9002,676-10.2%
Dividends paid1,5291,5081,395+1.4%
Dividend per sharen/an/a$5.92
Diluted shares, weighted225m233m237m-3.6%
Shares outstanding at period end221m227m233m-3.0%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity43,88241,31539,306+6.2%
Non-controlling interest14411199.0+29.7%
Short-term borrowings150n/an/a
Debt31,89631,23225,120+2.1%
Operating lease liabilities529658685-19.6%
Other liabilities44,89343,57343,718+3.0%
Total liabilities and equity121,494116,889108,928+3.9%
Fixed assets4,6794,6524,359+0.6%
Goodwill28,34428,27725,317+0.2%
Intangible assets11,20012,09410,273-7.4%
Investments27,00526,23630,490+2.9%
Cash and equivalents9,4918,2886,526+14.5%
Other assets40,77537,34231,963+9.2%
Total assets121,494116,889108,928+3.9%

10-K for the year ended 31 December 2025, filed 6 February 2026: the filing.